引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1072次   下载 773 本文二维码信息
码上扫一扫!
临床药师参与1例新生儿耐碳青霉烯类肺炎克雷伯菌感染的治疗实践
聂彩霞1,廖正辉,李合春,林意菊,尹思敏,邹治木,杨磊
0
(大理市第一人民医院,云南大理 671000)
摘要:
目的:探讨新生儿耐碳青霉烯类肺炎克雷伯菌的抗感染治疗的药学实践。方法:回顾性分析1例临床药师参与的新生儿耐碳青霉烯类肺炎克雷伯菌的抗感染治疗的案例。结果:临床药师结合药敏试验报告和患儿病情,参与抗感染治疗方案的制定并进行药学监护,最终使患儿感染得到控制并顺利出院。结论:在耐碳青霉烯类肺炎克雷伯菌的治疗中,临床药师应发挥专业优势,参与临床治疗,提高药物治疗的安全性和有效性
关键词:  临床药师  新生儿  耐碳青霉烯类肺炎克雷伯菌  抗感染治疗
DOI:10.13407/j.cnki.jpp.1672-108X.2022.03.005
基金项目:
Anti-Infective Treatment for a Case of Neonatal Carbapenem-Resistant Klebsiella Pneumoniae Participated by Clinical Pharmacists
Nie Caixia, Liao Zhenghui, Li Hechun, Lin Yiju, Yin Simin, Zou Zhimu, Yang Lei
(The First People’s Hospital of Dali, Yunnan Dali 671000, China)
Abstract:
Objective: To probe into the pharmaceutical practice of anti-infective treatment for neonatal carbapenem-resistant Klebsiella pneumoniae. Methods: Retrospective analysis was performed on anti-infective treatment for a case of neonatal carbapenem-resistant K. pneumoniae participated by clinical pharmacists. Results: In combination with the drug sensitivity test report and the disease condition of the child, the clinical pharmacists participated into the formulation of the anti-infective treatment regimen and provided pharmaceutical care for the child, the infection was controlled and the child successfully discharged from the hospital. Conclusion: In the treatment of carbapenem-resistant K. pneumoniae, clinical pharmacists should take advantages of the expertise and participate into the clinical treatment to improve the safety and effectiveness of drug therapy.
Key words:  clinical pharmacists  neonate  carbapenem-resistant Klebsiella pneumoniae  anti-infective treatment

用微信扫一扫

用微信扫一扫